Lunaphore Spatial Biology Technologies to be Featured at Spatial Biology US Conference
Lunaphore , a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced several presentations featuring the company’s spatial biology technologies at the Spatial Biology US conference taking place virtually September 27 – 30, 2021. Presentations will feature COMET™, Lunaphore’s all-in-one staining and imaging platform for high throughput, hyperplex immunofluorescence, and LabSat®, the company’s compact and open automated tissue staining instrument for immunohistochemistry and multiplex immunofluorescence.
How to Optimize a Hyper-Plex Immunostaining Panel in a Fast and Robust Manner
Date and time: September 29, 2021 / 4:30 – 5:00 PM ET
Speaker: Saska Brajkovic, Head of Application Development, Lunaphore
Spatial Proteomics: A Journey to Adopt New Highly Multiplexed Immunohistochemistry Technologies
Date and time: September 29, 2021 / 2:20 – 2:40 PM ET
Speaker: Alexander Klimowicz, Senior Principal Scientist, Boehringer Ingelheim
Live Q&A Session & Ask the Experts 2
Date and time: September 29, 2021 / 3:10 – 3:30 PM ET
Speakers: Alexander Klimowicz, Senior Principal Scientist, Boehringer Ingelheim; Barbara Cahill, Senior Global Portfolio Manager for Immunohistochemistry, Consumables and Cytology, Epredia
From One Week to One Day: Take Control of Your Research by Automating Tissue Microarrays, Multiplexing, Whole Slide Scanning and AI Analysis for Enhanced Bioinformatics
Date and time: September 29, 2021 / 8:40 – 9:10 AM ET
Speaker: Barbara Cahill, Senior Global Portfolio Manager for Immunohistochemistry, Consumables and Cytology, Epredia
1 Not sponsored by Lunaphore.
2 Sponsored by Epredia, exclusive distributor of LabSat® in the US, Germany and UK.
Lunaphore Technologies S.A. is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology which can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next generation personalized therapies. For further information on Lunaphore and its products, please visit www.lunaphore.com .
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
PROMPERÚ22.10.2021 19:17:07 CEST | Press release
Peru Holds a Ribbon Cutting Ceremony at Its Pavilion at Dubai Expo and Wins 4 World Travel Awards
TX-SCHLUMBERGER-LIMITED22.10.2021 12:52:09 CEST | Press release
Schlumberger Announces Third-Quarter 2021 Results
DISRUPTIVE.ASIA22.10.2021 12:32:08 CEST | Press release
Disruptive.Asia: Huawei's Ryan Ding and Peng Song Discuss How Operators Can Leverage Connectivity to Unlock New Growth
SUZANO22.10.2021 12:21:06 CEST | Press release
Suzano Brings Its Target for Capturing 40 Million Tons of Carbon From the Atmosphere Forward To 2025
ANT-GROUP22.10.2021 12:03:04 CEST | Press release
AntChain Launches Its First Security Chip and New Blockchain Platform Powered by Privacy Computing Technology
TOTAL-TELECOM22.10.2021 12:02:04 CEST | Press release
Total Telecom: Maximizing the Value of Connectivity
EGLE-THERAPEUTICS22.10.2021 11:32:10 CEST | Press release
Egle Therapeutics Raises 40 Million € Series a to Develop First-In-Class T-regulatory Cells Therapies Based On Treg-starvers
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom